secwatch / observer
8-K filed June 20, 2024, 7:59 PM ET ticker JSPR CIK 0001788028
leadership confidence high sentiment neutral materiality 0.50

Jasper Therapeutics appoints Svetlana Lucas to Board; Anna French resigns

Jasper Therapeutics, Inc.

item 5.02item 8.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001213900-24-053982
form_type
8-K
ticker
JSPR
cik
0001788028
company_name
Jasper Therapeutics, Inc.
filed_at
2024-06-20T23:59:59+00:00
discovered_at
2026-05-14T18:03:20.120828+00:00
generated_at
2026-06-01T03:37:08.001388+00:00
sec_items
["5.02", "8.01", "9.01"]
event_type
leadership
sentiment
neutral
materiality_score
0.5
calibrated_materiality_score
0.5
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001213900-24-053982
json_url
https://secwatch.observer/filing/0001213900-24-053982.json
markdown_url
https://secwatch.observer/filing/0001213900-24-053982.md
text_url
https://secwatch.observer/filing/0001213900-24-053982.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1788028/000121390024053982/0001213900-24-053982-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1788028/000121390024053982/ea0208074-8k_jasper.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Anna French

Director
JSPR · Jasper Therapeutics, Inc.
Effective
2024-06-18
Successor
Svetlana Lucas
Filed
June 20, 2024, 7:59 PM ET
On June 17, 2024, Anna French, D.Phil. notified the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) of her intent to resign from the Board effective as of June 18, 2024.
Appointed

Svetlana Lucas

Class III Director
JSPR · Jasper Therapeutics, Inc.
Effective
2024-06-18
Filed
June 20, 2024, 7:59 PM ET
Effective immediately following Dr. French’s resignation, on June 18, 2024, the Board appointed Svetlana Lucas, Ph.D. as a Class III director of the Company.

Source-grounded claims

932297e83c

Anna French resigned as Director at Jasper Therapeutics, Inc..

On June 17, 2024, Anna French, D.Phil. notified the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) of her intent to resign from the Board effective as of June 18, 2024.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

a571f3aa62

Svetlana Lucas was appointed as Class III Director at Jasper Therapeutics, Inc..

Effective immediately following Dr. French’s resignation, on June 18, 2024, the Board appointed Svetlana Lucas, Ph.D. as a Class III director of the Company.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Comparable filings

ACRG

ACRG announces fractional executive transitions and new consultant for Nevada project

American Clean Resources Group, Inc. May 28, 2026, 8:45 PM ET leadership Items 5.02, 8.01, 9.01

same fact type: executive_change same SEC item: 5.02, 8.01, 9.01 same event type: leadership similar materiality

This filing

On June 17, 2024, Anna French, D.Phil. notified the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) of her intent to resign from the Board effective as of June 18, 2024.

Comparable filing

Michael Raabe Effective February 2, 2026, Michael Raabe transitioned from his role as fractional Chief Operating Officer of the Company to a fractional strategic operations and project management support role.

Filing page SEC filing

TKNO

Alpha Teknova director Irene Davis to retire; board reduced from 8 to 7; shareholder votes approved nominees and auditor

Alpha Teknova, Inc. June 1, 2026, 5:22 PM ET leadership Items 5.02, 5.07, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

On June 17, 2024, Anna French, D.Phil. notified the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) of her intent to resign from the Board effective as of June 18, 2024.

Comparable filing

On May 27, 2026, Irene Davis, a member of the Board of Directors (the “Board”) of Alpha Teknova, Inc. (the “Company”) and a member of the Nominating and Corporate Governance Committee, notified the Company of her intention not to stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders (the “Meeting”) and to retire from the Board and all committees thereof, effective upon the date of the Meeting.

Filing page SEC filing

WTTR

Select Water Solutions COO Skarke moves to Chief Commercial Officer; no successor named

Select Water Solutions, Inc. June 1, 2026, 5:00 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

On June 17, 2024, Anna French, D.Phil. notified the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) of her intent to resign from the Board effective as of June 18, 2024.

Comparable filing

Effective June 1, 2026, Michael C. Skarke transitioned from serving as the Executive Vice President and Chief Operating Officer of Select Water Solutions, Inc. (the “Company”) to serving as the Company’s Executive Vice President and Chief Commercial Officer,

Filing page SEC filing

LPX

LP Building Solutions announces CFO succession: Alan Haughie to retire; Aaron Howald named CFO effective Sept 1, 2026

LOUISIANA-PACIFIC CORP June 1, 2026, 4:31 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

On June 17, 2024, Anna French, D.Phil. notified the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) of her intent to resign from the Board effective as of June 18, 2024.

Comparable filing

On May 27, 2026, Alan J.M. Haughie, Executive Vice President and Chief Financial Officer of Louisiana-Pacific Corporation (“LP”, the “Company”), notified the Board of Directors of LP (the “Board”) of his intention to retire from the role of Executive Vice President and Chief Financial Officer, effective September 1, 2026.

Filing page SEC filing

LOGC

ContextLogic appoints Scott Stewart as CFO & COO effective June 1; interim CFO resigns

ContextLogic Holdings Inc. June 1, 2026, 4:15 PM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

On June 17, 2024, Anna French, D.Phil. notified the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) of her intent to resign from the Board effective as of June 18, 2024.

Comparable filing

On June 1, 2026 the Company also announced the appointment of Scott Stewart, age 53, as Chief Financial Officer and Chief Operating Officer, effective June 1, 2026 (the “Effective Date”).

Filing page SEC filing

VMI

Former CFO Thomas Liguori enters separation agreement; $4.9M retirement benefits

VALMONT INDUSTRIES INC June 1, 2026, 4:15 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

On June 17, 2024, Anna French, D.Phil. notified the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) of her intent to resign from the Board effective as of June 18, 2024.

Comparable filing

Valmont Industries Inc. previously reported the appointment of John Schwietz as Valmont’s Executive Vice President and Chief Financial Officer and Corporate Secretary, effective April 8, 2026, to succeed Thomas Liguori.

Filing page SEC filing

PSQH

PSQ Holdings SVP of People Michael Hebert resigns; severance of $137,500

PSQ Holdings, Inc. June 1, 2026, 4:02 PM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

On June 17, 2024, Anna French, D.Phil. notified the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) of her intent to resign from the Board effective as of June 18, 2024.

Comparable filing

On May 26, 2026, Michael Hebert resigned from his position of Senior Vice President of People of PSQ Holdings, Inc. (the “Company”), effective May 31, 2026.

Filing page SEC filing

MGNO

Magnolia Bancorp names Robert Kimbro President/CEO; Hurley becomes Executive Chair

Magnolia Bancorp, Inc. June 1, 2026, 2:15 PM ET leadership Items 5.02, 5.07, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

On June 17, 2024, Anna French, D.Phil. notified the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) of her intent to resign from the Board effective as of June 18, 2024.

Comparable filing

On May 28, 2026, both the Company and the Association appointed Robert W. Kimbro as their President and Chief Executive Officer effective as of June 1, 2026.

Filing page SEC filing

Source: SEC EDGAR
accession 0001213900-24-053982
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.